TIS 0.00% 0.0¢ tissue therapies limited

company predictions

  1. 472 Posts.
    lightbulb Created with Sketch. 12
    Thought in the midst of all this banter I'd have a look back over past company predictions and see how accurate or inaccurate they were.

    20/12/2012
    Predicted:
    Q1-2 2011 for conducting EU trial - Correct even though delayed a bit by weather - results published 14/7/11
    Q3-4 2011 for EU approval for sale - Woefully out on that one.

    30/9/2011
    Predicted:
    - Commercialisation announcement in November 2011. Actual announcement was 28/11/2011 so spot on with that.
    - Sales to start in Q2 2012. Obviously missed but unknown by how much
    - Full trial report in Oct 2011. Not quite - 11/11/2011
    - FDA classification in Oct 2011. Missed by a day - 1/11/2011
    - FDA trial recruitment Dec 2011. Well that didn't happen. Can't remember why or if there has been an announcement.

    28/11/2011
    Predicted:
    - Q1 2012 FDA trial start. As above
    - Q2 2012 Sales to start. As above

    2/12/2011
    Predicted:
    - Q2 2012 SAles. As above.

    8/2/2012
    Predicted:
    - Early June 2012 SAles. As above.

    27/3/2012
    - End of May CE Mark approval. Didn't happen. Linked to sales.
    - End of June 2012 SAles. As above.

    Hope this is a balanced view. I'm sure I'll be corrected if not.

    It does occur to me though that a timeframe of about 1 year from final trial to commercialisation to approval to sales seems to be pretty good work.

    Yes, I know some are frustrated and if your financial future is riding on a speedy result then I feel for you. I certainly don't mean to disregard your anxiety.

    Rev
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.